MiRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma

Research output: Contribution to JournalReview articleAcademicpeer-review

34 Citations (Scopus)


Cholangiocarcinoma (CCA) is a lethal malignancy originating from the biliary tract epithelium. Most patients are diagnosed at an advanced stage. Even after resection with curative intent, prognosis remains poor. Previous studies have reported the evolving role of miRNAs as novel biomarkers in cancer diagnosis, prognostication and chemotherapy response. Various miRNAs, such as miR-21, miR-26, miR-122 and miR-150, have been identified as possible blood-based biomarkers for noninvasive diagnosis of CCA. Moreover, epithelial-mesenchymal transition (EMT)- and angiogenesis-associated miRNAs have been implicated in tumor cell dissemination and are able to determine clinical outcome. In fact, miRNAs involved in cell survival might even determine chemotherapy response. This review provides an overview of known miRNAs as CCA-specific biomarkers.

Original languageEnglish
Pages (from-to)1343-1358
Number of pages16
Issue number14
Early online date2017
Publication statusPublished - 1 Sep 2017


  • bile duct cancer
  • cholangiocarcinoma
  • diagnosis
  • liquid biopsy
  • miRNA
  • prediction
  • prognosis

Cite this